STEVENSON, Md., Dec. 29, 2014 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Roka Bioscience, Inc. ("Roka" or the "Company") (Nasdaq:ROKA) securities pursuant or traceable to the Company's initial public offering, which commenced on or about July 17, 2014 (the "IPO" or "Offering"), including those who purchased or otherwise acquired Roka common stock between July 17, 2014 and November 6, 2014, inclusive (the "Class Period"). Investors who wish to become proactively involved in the litigation have until February 23, 2015 to seek appointment as lead plaintiff.
If you have suffered a loss from investment in Roka securities purchased on or after July 17, 2014 and held through the revelation of negative information during and/or at the end of the Class Period, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616. No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company common stock during the Class Period. Brower Piven also encourages anyone with information regarding the Company's conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
The complaint accuses the defendants of violations of the Securities Act of 1933 by virtue of Roka's failure to disclose in the Offering documents known trends and uncertainties about the demand for its Atlas instrument used to detect foodborne pathogens. According to the complaint, after the Company's November 6, 2014 announcement that in the third quarter of 2014 it had not placed any Atlas instruments in the marketplace and suffered an unexpected loss for the quarter, the value of Atlas shares declined significantly.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.